As of 2024-12-14, the Fair Value of TRYP Therapeutics Inc (TRYP.CN) is -0.25 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.06 CAD, the upside of TRYP Therapeutics Inc is -514.28%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | - | 5Y Avg | |
| Net income | -8.25 | -7.50 | -5.27 | - | -7.01 | |
| YoY growth | -1,853.31% | 9.20% | 29.73% | - | -604.79% | |
| Market Cap (mil) | 5.79 |
| P/E | |
| Forward P/E |
| EPS | -0.05 |
| Avg earnings growth rate | -604.79% |
| TTM earnings | -4.79 |